𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancer

✍ Scribed by Charrier, S; Chassagne, J; Curé, H; Bay, J O; Communal, Y; Portefaix, G; Ferrière, J P; Bétail, G; Plagne, R; Chollet, P

Book ID
110010763
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
78 KB
Volume
22
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Release of peripheral blood progenitor c
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy
✍ Marco Venturini; Lucia Del Mastro; Ornella Garrone; Riccardo Rosso; Giovanni Mel 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Background. High dose chemotherapy with the support of peripheral blood progenitor cells (PBPC) is increasingly used in the treatment of solid tumors. Although the best method of PBPC mobilization is still under investigation, it should be optimized for different tumor types to obtain antitumor effe

Mobilization, collection, and characteri
Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma
✍ Carmelo Bengala; Ilaria Pazzagli; Carmelo Tibaldi; Claudio Favre; Renato Vanacor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Background: As single agents, both paclitaxel and epirubicin in combination with cytokines can mobilize peripheral blood progenitor cells (pbpcs). the authors have demonstrated previously that the combination of epirubicin and paclitaxel is very active against metastatic breast carcinoma and tol